136 Preliminary Safety and Efficacy of Myeloablative Orca-Q with No GvHD Prophylaxis for Treatment of Advanced Hematologic Malignancies

Amandeep Salhotra, MD, Mehrdad Abedi, MD, Samer A. Srour, MB ChB, MS, Rasmus T. Hoeg, MD, Edmund K. Waller, MD, PhD, Hannah K. Choe, MD, Anna Pavlova, MD, PhD, Tamara Zharkevich, James Scott McClellan, MD, PhD, Nathaniel B. Fernhoff, PhD, Everett H. Meyer, MD, PhD, and Robert Lowsky, MD  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665505

138 C Observational Comparison of Overall Survival between Phase 1b Orca-T and Registry-Based Post-Transplant Cyclophosphamide Patients

Everett H. Meyer, MD, PhD, Samer A. Srour, MB ChB, MS, Caspian Oliai, MD, MS, Rasmus T. Hoeg, MD, Arpita P. Gandhi, MD, Lori S. Muffly, MD, Rohtesh S. Mehta, MD, MPH, MS, Edmund K. Waller, MD, PhD, Robert Lowsky, MD, Sagar S. Patel, MD, Dr. Bhagirathbhai Dholaria, MBBS, Jeremy Pantin, MD, Amandeep Salhotra, MD, Joseph P McGuirk, DO , Steven M. Devine, MD, Alexandra Gomez-Arteaga, MD, Rawan Faramand, MD, Roni Tamari, MD, Jennifer L. Holter-Chakrabarty, MD, Betty K. Hamilton, MD, Antonio Jimenez, MD, Anna Pavlova, MD, PhD, Nathaniel B. Fernhoff, PhD, James Scott McClellan, MD, PhD, Mehrdad Abedi, MD, and Robert S. Negrin, MD  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665506

144 Frequency of Deleterious Pathogenic/Likely Pathogenic Germline Variants in Related and Unrelated Allogeneic Hematopoietic Cell Transplant Donors for Patients with Myelodysplastic Syndrome

Ryan J. Stubbins, Zachary S. Hattig, Amy M. Trottier, Courtnee V. Rodgers, Yoga Haribabu, Lara Crone, Inge Govaerts, William Smith IV, MD, Mark Juckett, Michael R. Grunwald, Betul Oran, MD, MS, Hany Elmariah, Kennia Villa, Paul Auer, Soyoung Kim, Jing Dong, Zhongyuan Chen, Charimar Santiago Parrilla, Tao Zhang, Yung-Tsi Bolon, Stephen R. Spellman, MBS, Wael Saber, and Lucy A. Godley, MD, PhD  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665713

148 NGS MRD Negativity on Day 28 after Brexu Cel in Adults with R/R ALL Is Associated with Favorable Progression Free Survival

Yannis Valtis, David Nemirovsky, Sean Devlin, PhD, Gregory Roloff, MD, Nikeshan Jeyakumar, MD, Katharine Miller, PhD, Amy Zhang, MPH, Katherine C. Sutherland, PA, Michael R. Grunwald, Vamsi Kota, MD, Jacob Boccucci, MD, Matthew L. Ulrickson, MD, Ali Al Darobi, MD, LaQuisa C. Hill, MD, Ibrahim N. Muhsen, MD, Joshua P Sasine, MD, PhD, Mohamed Ahmed, MD, Ibrahim Aldoss, MD, Vinod Pullarkat, MD, Tamer Othman, MD, Anjali S. Advani, MD, Ran Reshef, MD, Marlise Luskin, MD, MSCE, Evan Chen, MD, Chenyu Lin, MD, Ryan D. Cassaday, MD, Dr. Stephanie B. Tsai, MD, Noam E. Kopmar, MD, Timothy E O'Connor, MD, Talal Hilal, MD, Bijal D Shah, MD, Rawan Faramand, MD, Melhem M Solh, MD, Caitlin Guzowski, Evandro Bezerra, MD, Sumithira Vasu, MBBS, Jessica T. Leonard, MD, Simone E. Dekker, MD, PhD, Navneet S. Majhail, MD, MS, FASTCT, Minoo Battiwalla, MD, MS, Shahbaz Malik, MD, John Mathews, MD, Paul Shaughnessy, MD, Luke Mountjoy, DO , Rasmus T. Hoeg, MD, Caspian Oliai, MD, MS, Vishal K. Gupta, MD, Divya Koura, MD, Kaitlyn C. Dykes, MD, Aaron C Logan, MD, PhD, Muthu V. Kumaran, MD, Wendy Stock, MD, Marc Schwartz, MD, Veronika Bachanova, Sean Tracy, MD, PhD, Kristen M. O'Dwyer, MD, Jozal W. Moore, MD, Catherine J. Lee, MD, MS, Maria Silvina Odstrcil Bobillo, MD, Noelle V. Frey, MD, Matthew P. Connor, MD, Omer Jamy, MD, Michael Daunov, DO, Dr. Abdullah Ladha, MD, MPH, George Yaghmour, Vivian Irizarry Gatell, MD, Clayton Jackson, MD, Olalekan O Oluwole, MD, MBBS, Dr. Bhagirathbhai Dholaria, MBBS, Lori S. Muffly, MD, and Jae H Park  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665508

150 Allogeneic Hematopoietic Cell Transplant Following Standard of Care Brexucabtagene Autoleucel (Brexu-cel) in Adults with B-Cell Acute Lymphoblastic Leukemia (B-ALL): Results from the Real-World Outcomes Collaborative of CAR T in Adult ALL (ROCCA)

Rawan Faramand, MD, Gregory Roloff, MD, Ibrahim Aldoss, MD, Amy Zhang, MPH, Katherine C. Sutherland, PA, Nikeshan Jeyakumar, MD, Katharine Miller, PhD, Vamsi Kota, MD, Jacob Boccucci, MD, Matthew L. Ulrickson, MD, Ali Al Darobi, MD, Tamer Othman, MD, Anjali S. Advani, MD, Maryann Stefan, Chenyu Lin, MD, Ryan D. Cassaday, MD, Noam E. Kopmar, MD, Dr. Stephanie B. Tsai, MD, Timothy E O'Connor, MD, Talal Hilal, MD, Melhem M Solh, MD, Caitlin Guzowski, Jessica T. Leonard, MD, Virginia Tan, MD, Navneet S. Majhail, MD, MS, FASTCT, Minoo Battiwalla, MD, MS, Shahbaz Malik, MD, John Mathews, MD, Paul Shaughnessy, MD, Luke Mountjoy, DO, Divya Koura, MD, Kaitlyn C. Dykes, MD, Aaron C Logan, MD, PhD, Marc Schwartz, MD, Kristen M O'Dwyer, MD, Jozal W. Moore, MD, Catherine J. Lee, MD, MS, Maria Silvina Odstrcil Bobillo, MD, Noelle V. Frey, MD, Matthew P. Connor, MD, Dr. Abdullah Ladha, MD, MPH, George Yaghmour, Bijal D Shah, MD, and Lori S. Muffly, MD  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665718

154 Tyrosine Kinase Inhibitor (TKI) Maintenance Improves Remission Durability in Philadelphia-Chromosome Acute Lymphoblastic Leukemia (Ph+ ALL) Following Brexucabtagene Autoleucel (Brexu-cel)

Tamer Othman, MD, Vinod Pullarkat, MD, Gregory Roloff, MD, Nikeshan Jeyakumar, MD, Katharine Miller, PhD, Amy Zhang, MPH, Katherine C. Sutherland, PA, LaQuisa C. Hill, MD, Ibrahim N. Muhsen, MD, Josh Sasine, MD, PhD, Mohamed Ahmed, MD, Anjali S. Advani, MD, Maryann Stefan, Chenyu Lin, MD, Ryan D. Cassaday, MD, Noam E. Kopmar, MD, Dr. Stephanie B. Tsai, MD, Timothy E O'Connor, MD, Talal Hilal, MD, Bijal D Shah, MD, Rawan Faramand, MD, Melhem M Solh, MD, Caitlin Guzowski, Jessica T. Leonard, MD, Virginia Tan, MD, Navneet S. Majhail, MD, MS, FASTCT, Minoo Battiwalla, MD, MS, Shahbaz Malik, MD, John Mathews, MD, Paul Shaughnessy, MD, Luke Mountjoy, DO, Divya Koura, MD, Kaitlyn C. Dykes, MD, Aaron C Logan, MD, PhD, Marc Schwartz, MD, Kristen M O'Dwyer, MD, Jozal W. Moore, MD, Catherine J. Lee, MD, MS, Maria Silvina Odstrcil Bobillo, MD, Noelle V. Frey, MD, Matthew P. Connor, MD, Dr. Abdullah Ladha, MD, MPH, George Yaghmour, Lori S. Muffly, MD, and Ibrahim Aldoss, MD  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665722

162 Development of a Circulating Free DNA (cfDNA) Assay for the Detection of Measurable Residual Disease to Predict Relapse in Patients with B-Cell Acute Lymphoblastic Leukemia
Chandan Sanghera, MBBS, Nikeshan Jeyakumar, MD, Parveen Shiraz, MD, Matthew Frank, MD, PhD, Saurabh Dahiya, MD, Melody Smith, MD, Michael Khodadoust, MD, PhD, Crystal L. Mackall, M.D., David B. Miklos, MD, PhD, David Kurtz, MD, PhD, and Lori S. Muffly, MD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/666729

177 Early Steroid and Anakinra Use to Manage Axicabtagene Ciloleucel Toxicity Reduces the Total Duration of CRS and Icans
William Lee Wang, BA, Dasom Lee, MD, Edna Cheung, PharmD, Alexandria Jensen, PhD, Mark P. Hamilton, MD, PhD, Masooma Shifa Rana, MD, Anmol Goyal, MD, Nima Ghalehsari, MD, Theresa M. Latchford, MS, RN, CNS, BMTCN, AOCNS, Brian J. Scott, MD, Jayasindhu Mallampet, Claire Lohman, Bita Sahaf, PhD, Surbhi Sidana, MD, Wen-Kai Weng, MD, PhD, Melody Smith, MD, Sushma Bharadwaj, MD, Matthew Frank, MD, PhD, David B. Miklos, MD, PhD, and Saurabh Dahiya, MD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665587

184 Prognostic Accuracy of Transplant Clinicians Compared to Recipients of Allogeneic Hematopoietic Cell Transplantation Who Are Older, Medically Infirm, and/or Frail and Enrolled in an Ongoing Seamless Phase 2/3 Randomized Interventional Trial (ACE-BMT)

Elizabeth T. Loggers, MD, PhD, James Fausto, MD, Matthew Givens, MD, Mei-Ean Yeow, Reena V Jayani-Kosarzycki, MD, Hassan B. Alkhateeb, MD, Michael W. Rabow, Mark Juckett, Kyle Neale, Diana Martins-Welch, Laura S Rhee, Susan McInnes, MD, Santiago Lopez, Sara F Martin, MD, Rachel Cook, MD, Rebecca L. Olin, MD, MSCE, Laura Johnston, MD, Elisheva Newman, Ronald M. Sobecks, MD, and Mohamed L. Sorror, MD, MSc  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665594

203 Exploring Vitamin D Monitoring and Supplementation Strategies in HCT Patients at an Academic Medical Center

Tara Coghlin Dickson, MS, RD, CSSD, FAND, Kylie Chen, MS, RD, Laura Johnston, MD, and Anna Oh, PhD, MPH, RN

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/666742

210 Regulatory T Cell-Mediated Selective Deletion of Islet ß Antigen-Specific Autoreactive T Cells in Type 1 Diabetes 

Shiva Pathak, PhD, Cameron S. Bader, Bettina P. Iliopoulou, PhD, Shobha Regmi, Pin-I Chen, PhD, Xiangni Wu, Suparna Dutt, PhD, Kayla Chanelle Jenkins, Nadine Nagy, PhD, Kent P. Jensen, PhD, and Everett H. Meyer, MD, PhD  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/666762

229 Challenges and Efficient Management of Cryopreserved Cell Product Inventory
Thomas Orozco, KymHuynh (Kymberly) Pham, Tran Pham, Rikin Patel, Eric Musa, Katlin Villar, Aman Siddiqui, Catherine McIntyre, PhD, and Robert Lowsky, MD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665449

272 Targeting Monocytes with Human Folate Receptor β Chimeric Antigen Receptor (CAR)-CD39+ Treg Subset Improves Immune Regulatory Function of the Monocytes That May Restore Tolerance in Autoimmune Diseases

Pin-I Chen, PhD, Xiangni Wu, Kent P. Jensen, PhD, Magdiel Perez Cruz, PhD, Shiva Pathak, PhD, Cameron Bader, PhD, Bettina Iliopoulou, PhD, and Everett H. Meyer, MD, PhD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665704

273 Engineered Invariant Natural Killer T Cells (iNKT cells) Targeting CD 117 As a Novel Treatment for Acute Myeloid Leukemia

Chaiyaporn Boonchalermvichian, MD, PhD, Hao Yan, PhD, Jeanette Baker, Quenton Rashawn Bubb, MPhil, PhD, Biki Gupta, PhD, Agnieszka Czechowicz, MD, PhD, and Robert S. Negrin, MD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665705

275 Single-Cell and Bulk RNA Sequencing Analysis of Adult Patients with Acute Myeloid Leukemia to Identify Potential for Transferability of Pediatric Trivalent CAR-T Approaches

Gabriel E Seir, BS, Quenton Rashawn Bubb, MPhil, PhD, Gabriel Salzman, MD, PhD, Agnieszka Czechowicz, MD, PhD, Tian Y Zhang, MD, PhD, and Vanessa E Kennedy, MD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/666712

283 Axicabtagene Ciloleucel (Axi-Cel) Versus Standard of Care (SOC) in Patients with Primary Refractory or Early Relapsed Large B-Cell Lymphoma (LBCL)

Jason R. Westin, MD, MS, FACP, Olalekan O Oluwole, MD, MBBS, Marie José Kersten, MD, PhD, David B. Miklos, MD, PhD, Miguel-Angel Perales, MD, Armin Ghobadi, MD, Aaron P. Rapoport, MD, Anna Sureda, MD, PhD, Caron A. Jacobson, MD, MMSc, Umar Farooq, MD, Matthew L. Ulrickson, MD, Tom van Meerten, MD, PhD, Mahmoud Elsawy, MD, MSc, DRCPSC, Sridhar Chaganti, MD, PhD, Michael Dickinson, MBBS, DMSc, FRACP, FRCPA, Lori A. Leslie, MD, Peter Vandenberghe, MD, PhD, Yin Yang, MD, MS, Christina To, MD, Simone Filosto, PhD, Justin Budka, PhD, Saran Vardhanabhuti, PhD, and Frederick L Locke, MD  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665648

285 KMT2Ar Adversely Impacts Brexucabtagene Autoleucel (Brexu-cel) Outcome in Adults with Relapsed/ Refractory (r/r) B-Cell Acute Lymphoblastic Leukemia

Virginia Tan, MD, Abdullah Ladha, MD MPH, George Yaghmour , Amy Zhang, MPH, Nikeshan Jeyakumar, MD, Katharine Miller, PhD, Ibrahim N. Muhsen, MD, Aaron C Logan, MD, PhD, LaQuisa C. Hill, MD, Ryan D. Cassaday, MD, Marlise Luskin, MD, MSCE, Matthew L. Ulrickson, MD, Melhem M Solh, MD, Yannis Valtis, Minoo Battiwalla, MD, MS, Veronika Bachanova, Jacob Boccucci, MD, Ran Reshef, MD, Dr. Stephanie B. Tsai, MD, Rasmus T. Hoeg, MD, Vamsi Kota, MD, Tamer Othman, MD, Anjali S. Advani, MD, Joshua P Sasine, MD, PhD, Mohamed Ahmed, MD, Ali Al Darobi, MD, Vinod Pullarkat, MD, Maryann Stefan, Evan C. Chen, MD, Chenyu Lin, MD, Noam E. Kopmar, MD, Catherine J. Lee, MD, MS, Maria Silvina Odstrcil Bobillo, MD, Timothy E O'Connor, MD, Talal Hilal, MD, Bijal D Shah, MD, Rawan Faramand, MD, Jae H Park, Caitlin Guzowski , Sumithira Vasu, MBBS, Evandro Bezerra, MD, Navneet S. Majhail, MD, MS, FASTCT, Paul Shaughnessy, MD, Shahbaz Malik, MD, John Mathews, MD, Luke Mountjoy, DO , Muthu V. Kumaran, MD, Divya Koura, Kaitlyn C. Dykes, MD, Caspian Oliai, MD, MS, Vishal K. Gupta, MD, Wendy Stock, MD, Sean Tracy, MD, PhD, Kristen M O'Dwyer, MD, Noelle V. Frey, MD, Jozal W. Moore, MD, Matthew P. Connor, MD, Olalekan Oluwole, MBBS MPH, Dr. Bhagirathbhai Dholaria, MBBS, Gregory Roloff, MD, Katherine C. Sutherland, PA, Lori S. Muffly, MD, Ibrahim Aldoss, MD  and Jessica T. Leonard, MD  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665484

316 Point-of-Care Bispectral Electroencephalogram (BSEEG) As a New Tool in Detecting Immune Effector Cell Associated Neurotoxicity (ICANS) in Patients Treated with Chimeric Antigen Receptor T-Cell (CAR-T)

Sylvester Homsy, MD, Tomoteru Seki, MD, PhD, Hieu Dinh Nguyen, Akiyoshi Shimura, Nipun Gorantla, Nathan James Phuong, Therese Anne Santiago, Nima Ghalehsari, MD, Arash Velayati, MD, MBA, Nikeshan Jeyakumar, MD, Mark P. Hamilton, MD, PhD, Vanessa E Kennedy, MD, Lekha Mikkilineni, MD, Sushma Bharadwaj, MD, Melody Smith, MD, Saurabh Dahiya, MD, Matthew Frank, MD, PhD, Lori S. Muffly, MD, Surbhi Sidana, MD, Wen-Kai Weng, MD, PhD, David B. Miklos, MD, PhD, Hitomi Hosoya, MD PhD, and Gen Shinozaki, MD  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/666802

318 Rapid Increase in Blood CD19 CAR-T Vector Load during the First 5 Days Post Infusion Is Associated with Severe Icans 

Sushma Bharadwaj, MD, Courtney Smith, Jenny Nater, MS, Saran Vardhanabhuti, PhD, Daisy Ding, Jayasindhu Mallampet , Betty Chang, Brian Smith, Andrew Jallouk, MD, PhD, Andre de Menedez Silva Corraes, Kevin Regan, Zuoyi Shao, Sarah Elkordy, Jing Fang, Abigail Twoy, Shriya Syal, MS, Katrijn Broos, Jan Wuyts, Gorik Braem , Tom Adriany, Bita Sahaf, PhD, Katherine A. Kong, Mark P. Hamilton, MD, PhD, Geert Maertens, Sofie Metsu, Mike Mattie, PhD, Melody Smith, MD, Matthew Frank, MD, PhD, Saurabh Dahiya, MD, Robert Tibshirani , Olalekan O Oluwole, MD, MBBS, Yi Lin, MD, PhD, Rhine R. Shen, PhD, and David B. Miklos, MD, PhD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/666804

329 CD117 CAR-iNKT Cells As a Safe and Effective Off-the-Shelf Allogeneic Cell Therapy for AML

Hao Yan, PhD, Chaiyaporn Boonchalermvichian, MD, PhD, Biki Gupta, PhD, Sisi Wang, Jeanette Baker, Federico Simonetta, MD, PhD, and Robert S. Negrin, MD 

https://tandem.confex.com/tandem/2024/meetingapp.cgi/Paper/23907

372 Next Generation Immune Tolerance Conditioning: Anti-CD3 T Cell Depletion with OrthoCD3 Shielding of Regulatory T Cells

Yong Bin "Phil" Kim, BS, Pin-I Chen, PhD, Bettina P. Iliopoulou, PhD, Levon Witherspoon, Nadine Nagy, PhD, Cameron S. Bader, PhD, Kent P. Jensen, PhD, Jennifer R. Cochran, PhD, and Everett H. Meyer, MD, PhD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665691

378 Host-Derived Immunoregulatory Invariant Natural Killer T Cell Subset, iNKT2 Is Instrumental for Prevention of Acute Graft Versus Host Disease in Mice

Biki Gupta, PhD, Jeanette Baker, Shiva Pathak, PhD, Hao Yan, PhD, and Robert S. Negrin, MD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665697

380 Phase 1 Trial Results for Patients with Advanced Hematologic Malignancies Treated with Allogeneic T Cell Immunotherapy and Reduced Intensity Conditioning

Alejandro Villar-Prados, MD/PhD, Katherine Sutherland, Robert S. Negrin, MD, Sally Arai, MD, Matthew Frank, MD, PhD, Laura Johnston, MD, Robert Lowsky, MD, David B. Miklos, MD, PhD, Lori S. Muffly, MD, Saurabh Dahiya, MD, Andrew R. Rezvani, MD, Surbhi Sidana, MD, Parveen Shiraz, MD, Judith A. Shizuru, MD, PhD, Wen-Kai Weng, MD, PhD, Melody Smith, MD, Sushma Bharadwaj, MD, John Tamaresis, Ph.D, Anna Pavlova, MD, PhD, James Scott McClellan, MD, PhD, and Everett H. Meyer, MD, PhD  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665543

381 The Phase 2 Stargaze Trial of the Glucagon-like Peptide 2 (GLP-2) Analog Apraglutide in Combination with Ruxolitinib for Steroid-Refractory Gastrointestinal (GI) Acute Graft-Versus-Host Disease (aGvHD): Comparisons with a MAGIC Control Cohort

Robert Zeiser, MD, James L.M. Ferrara, MD, DSc, Ioannis Evangelos Louloudis, MD, Nikolaos Katsivelos, MD, Udo Holtick, MD, PhD, Eva Maria Wagner-Drouet, MD, Sally Arai, MD, Holger G. Adelmann, MD, PhD, Nader N. Youssef, MD, MBA, Anastasia Eremeeva, MSc, Francois Collin, PhD, Hannah K. Choe, MD, Yi-Bin Chen, MD, and John E. Levine, MD  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665544

399 Kinetics and Management of Hepatic Laboratory Elevations Associated with Axatilimab in the Agave-201 Study

Hannah K. Choe, MD, Sally Arai, MD, Panagiotis Tsirigotis, MD, Bruno Lioure, MD, Daniele Avenoso, MD, PhD, Vedran Radojcic, MD, Britnie Thomas, PhD, Jaicha Valerio, PharmD, Shuyuan Lou, PhD, and Carrie L. Kitko, MD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665562

417 Comparison of Post-Transplant Cyclophosphamide Vs Methotrexate and Calcineurin Inhibitor for Gvhd Prophylaxis in Myeloablative Transplants with HLA Matched Donors

Vanessa E Kennedy, MD, Parveen Shiraz, MD, Sally Arai, MD, Laura Johnston, MD, Andrew R. Rezvani, MD, Judith A. Shizuru, MD, PhD, Everett H. Meyer, MD, PhD, Sushma Bharadwaj, MD, Lekha Mikkilineni, MD, Surbhi Sidana, MD, Hitomi Hosoya, MD PhD, Wen-Kai Weng, MD, PhD, Saurabh Dahiya, MD, Matthew Frank, MD, PhD, Melody Smith, MD, Robert S. Negrin, MD, David B. Miklos, MD, PhD, and Lori S. Muffly, MD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/666674

459 Proinflammatory Mediators Leading to Graft Transition Syndrome in the Context of Living Donor Kidney Transplantation
Kayla Chanelle Jenkins, Monali Manohar, PhD, Rahul Pawar, George Kuo, PhD, Kent P. Jensen, PhD, and Everett H. Meyer, MD, PhD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665455

463 Persistence of Alloreactive T Regulatory Cell Clones Correlates with Mixed Chimerism after Combined Kidney and Hematopoietic Cell Transplantation

Cameron S. Bader, PhD, Monali Manohar, PhD, Pin-I Chen, PhD, James M. Mathew, PhD, Joseph R. Leventhal, MD, PhD, Kent P. Jensen, PhD, Robert Lowsky, MD, Stephan Busque, MD, and Everett H. Meyer, MD, PhD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/666046

474 Impact of Obesity on Efficacy, Safety, and Expansion Kinetics of Chimeric Antigen Receptor T-Cell (CAR T) Therapy in Relapsed or Refractory Large B-Cell Lymphoma

Anmol Goyal, MD, Sushma Bharadwaj, MD, Eric Lau, DO, Alexandria Jensen, PhD, Mark P. Hamilton, MD, PhD, Caroline Lee, MD, Bita Sahaf, PhD, Shriya Syal, MS, Sunita Patil, MS, Juancarlos Cancilla, Theresa M. Latchford, MS, RN, CNS, BMTCN, AOCNS, and Saurabh Dahiya, MD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665990

509 Real-World Assessment of Patient Adherence to the Late Effects Screening Recommendations Among Hematopoietic Cell Transplantation Survivors

Neel Bhatt, MBBS, MPH, Elizabeth M. Hellewell, BS, Kevin Ng, MS, Ted A. Gooley, PhD, Allison O. Taylor, MD, MS, Sanghee Hong, MD, Anthony Sung, MD, Nausheen Ahmed, MD, Cherie Morey, NP, Sarah Fitzmaurice, NP, Vanessa E Kennedy, MD, Michelle Lauer, PA-C, MPH, Andrew D. Trunk, MD, Betty K. Hamilton, MD, Akshay Sharma, MBBS, MSc, Zoey Phelps-Bergeron, PA-C, LaQuisa C. Hill, MD, Rawan Faramand, MD, Hien Liu, MD, Lena E. Winestone, MD, MSHP, Geoffrey Cheng, MD, Manuel R. Espinoza-Gutarra, MD, Omer Jamy, MD, Maria Silvina Odstrcil Bobillo, MD, Brian McClune, DO, Mariam T Nawas, MD, Samuel J Yates, MD, MSc, Miki Nishitani, MD, Takuto Takahashi, MD, PhD, Dr. Jane Koo, MD, Kasiani Myers, MD, Kris Michael Mahadeo, MD, MPH, Andrea Bauchat, DO, Laurie Pearson, MD, Ritika Walia, MD, Kelsea Seago, PharmD, BCOP, Spencer Yingling, PharmD, BCOP, Cory Edgar, DMSc, MPAS, PA-C, Amy Browning, MSN, APRN, and Catherine J. Lee, MD, MS  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665795

517 Patient Reported Financial Toxicity Pre-Infusion for Adult Transplantation and Cellular Therapy Recipients: Results from CIBMTR PRO Data Collection

Rachel Cusatis, PhD, Jianqun Kou, MS, Caitrin Bupp, MPH, Michelle Kuxhausen, MS, Deborah Matilla, BA, Idayat M. Akinola, MBBS, MPH, Miranda Kapfhammer, BS, Sarah Smith, RN, BSN, Azhaar Mohamed, Melissa Michelli, Nandita Khera, MD, MPH, Betty K. Hamilton, MD, Lori S. Muffly, MD, Richard Newcomb, MD, Heather SL Jim, PhD, Corrigan Luetke, BA, Nina Lor, Bronwen E. Shaw, MD, PhD, and Kathryn E. Flynn, PhD 

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665491

546 CD22-Directed CAR T-Cell Therapy Achieves Complete Remission in CD19-Directed CAR T-Cell Refractory Follicular and Mantle Cell Lymphoma with Superior Safety and Absence of Neurotoxicity

Hrishikesh K. Srinagesh, MD, MSCR, Anne Marijn Kramer, MD, PhD, Mark P. Hamilton, MD, PhD, Yi-Jiun Su, MD, Kendall Levine, BS, Annie K Brown, Kimi F DeNoble, Sharon Mavroukakis, Claire Lohman, Kristen Cunanan, PhD, Neha Agarwal, Sushma Bharadwaj, MD, Warren D. Reynolds, BS, Sally Arai, MD, Laura Johnston, MD, Robert Lowsky, MD, Everett H. Meyer, MD, PhD, Robert S. Negrin, MD, Andrew R. Rezvani, MD, Judith A. Shizuru, MD, PhD, Lekha Mikkilineni, MD, Hitomi Hosoya, MD PhD, Parveen Shiraz, MD, Surbhi Sidana, MD, Wen-Kai Weng, MD, PhD, Vanessa E Kennedy, MD, Melody Smith, MD, Saurabh Dahiya, MD, Kara L Davis, D.O., Sneha Ramakrishna, M.D., Liora Schultz, M.D., Ramya Tunuguntla, Lori S. Muffly, MD, Crystal L. Mackall, M.D., Steven Feldman, PhD, David B. Miklos, MD, PhD, and Matthew Frank, MD, PhD 

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665961

555 Identifying Disparities in Autologous Hematopoietic Cell Transplantation (autoHCT) Utilization for Patients with Diffuse Large B-Cell Lymphoma (DLBCL) in California

Naseem Esteghamat, Ann Brunson, MS, Renata Abrahao, MD, MSc, PhD, Aaron Rosenberg, MD, Dr. Jeffery J. Auletta, MD, Sara J Schonfeld, PhD, Christa L. Meyer, MS, Julianne JP Cooley, Lori S. Muffly, MD, Lindsay M. Morton, PhD, Ted Wun, MD, and Theresa H.M. Keegan, PhD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665970

557 Idelalisib (Zydelig) Maintenance in B-Cell Non-Hodgkin's Lymphoma after Autologous Stem Cell Transplantation (HDT/ASCT)
Jean A. Yared, MD, Tanmay Singh, MD, Prof. Amer M. Beitinjaneh, MD, Aaron P. Rapoport, MD, Saurabh Dahiya, MD, Djordje Atanackovic, MD, Dr. Nancy Maureen Hardy, MD, Mehmet H. Kocoglu, MD, Tara Toth, PA-C, Deanna Pineiro, and Olga G. Goloubeva, PhD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665972

566 Ciltacabtagene Vicluecel (Cilta-cel) Chimeric Antigen Receptor T-Cell Therapy for Relapsed/Refractory Multiple Myeloma (RRMM) with Renal Impairment: Real World Experience

Surbhi Sidana, MD, Lauren C Peres, PhD, MPH, Leyla Shune, Alicia Richards, PhD, Mehmet H. Kocoglu, MD, Christopher James Ferreri, MD, Shebli Atrash, MD, Binod Dhakal, MD, Kinaya Smith, MD, Radhika Bansal, MBBS, Shonali Midha, MD, Danai Dima, Patrick Costello, Charlotte B. Wagner, PharmD, Hitomi Hosoya, MD, PhD, Lekha Mikkilineni, MD, Ran Reshef, MD, Djordje Atanackovic, MD, Saurabh Chhabra, MD, MS, Ricardo Daniel Parrondo, MD, Omar Nadeem, MD, Hashim Mann, Nilesh Kalariya, PhD, RN, AGPCNP-BC, Vanna Hovanky, Gabe De Avila, Ciara L Freeman, MD, PhD, Rebecca Gonzalez, PharmD, BCOP, Frederick L Locke, MD, Melissa Alsina, MD, Anupama Kumar , Megan M. Herr, PhD, Thomas Martin, Joseph P McGuirk, DO, Douglas W. Sborov, MD, Jack Khouri, MD, Yi Lin, MD, PhD, Krina K. Patel, MD, MS, and Doris K Hansen, MD  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665885

572 Post-CAR-T Driving Restrictions Appear Unnecessary after Week 4: Data from the US Multiple Myeloma Immunotherapy Consortium
Rahul Banerjee, MD, Alicia Richards, PhD, Jack Khouri, MD, Murali Janakiram, MD, MS, Kara I. Cicero, MD, Danai Dima, MD, Mehmet H. Kocoglu, MD, Leyla Shune, MD, Evguenia Bhurtel, MD, Dr. Tania Jain, MD, Aimaz Afrough, MD, Saurabh S. Zanwar, MBBS, Christopher James Ferreri, MD, Oren Pasvolsky, MD, Lekha Mikkilineni, MD, Dr. Sneha Purvey, MD, Lauren C Peres, PhD, MPH, Ciara L Freeman, MD, PhD, Shonali Midha, MD, Prof. Amer M. Beitinjaneh, MD, James A. Davis, PharmD, BCOP, Charlotte B. Wagner, PharmD, Megan M. Herr, PhD, Peter A. Forsberg, MD, Douglas W. Sborov, MD, Shambavi Richard, MD, Ran Reshef, MD, Binod Dhakal, MD, Veronika Bachanova, Joseph P McGuirk, DO, Peter M. Voorhees, Larry D. Anderson Jr., MD, PhD, Yi Lin, MD, PhD, Thomas G. Martin, MD, Surbhi Sidana, MD, Krina K. Patel, MD, MS, Doris K Hansen, MD, Andrew J. Cowan, MD, and Gurbakhash Kaur, MD 

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665891

574 Teclistamab (Tec) for Patients (pts) with Heavily Pretreated Relapsed/Refractory Multiple Myeloma (RRMM) and Renal Impairment: A Multicenter Study from the U.S. Multiple Myeloma Immunotherapy Consortium

Danai Dima, MD, Aimaz Afrough, MD, Utkarsh Goel, MBBS, Ariel Grajales-Cruz, MD, Jack Khouri, MD, Kelley L Julian, PharmD, BCOP, Oren Pasvolsky, MD, Rahul Banerjee, MD, Beatrice Razzo, MD, Christopher James Ferreri, MD, Mariola A Vazquez-Martinez, James A. Davis, PharmD, BCOP, Aishwarya Sannareddy, MBBS, Omar Castaneda, MD, Shahzad Raza, MD, Andrew J. Portuguese, MD, Mahmoud Gaballa, MD, Masooma Shifa Rana, Alex Lieberman-Cribbin, MPH, Mr. Shaun DeJarnette, BS, MT(ASCP), Rebecca Gonzalez, PharmD, BCOP, Anna Chen, Megan M. Herr, PhD, Lekha Mikkilineni, MD, Hitomi Hosoya, MD PhD, Evguenia Ouchveridze, MD, Gurbakhash Kaur, MD, Adriana Rossi, MD, Leyla Shune, Faiz Anwer, MD, Yi Lin, MD, PhD, Shambavi Richard, MD, Douglas W. Sborov, MD, Rachid C Baz, MD, Alfred L. Garfall, MD, Hans C. Lee, MD, Larry D. Anderson Jr., MD, PhD, Andrew J. Cowan, MD, Krina K. Patel, MD, MS, Peter M. Voorhees, Surbhi Sidana, MD, Doris K Hansen, MD, Shebli Atrash, MD, and Sandra Susanibar-Adaniya, MD  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665893

575 Dynamics of B Cell Maturation Antigen (BCMA) Expression Pre-Treatment and at Relapse in Patients with Relapsed/Refractory Multiple Myeloma Receiving BCMA Directed CAR-T Cell Therapy

Masooma Shifa Rana, MD, Alexandria Jensen, PhD, Lekha Mikkilineni, MD, Sebastian Fernandez-Pol, MD, PhD, Vanna Hovanky, Jean S. Oak, MD, PhD, Oscar Silva, MD, Ph.D, Lori S. Muffly, MD, Bita Sahaf, PhD, Sally Arai, MD, Vanessa E Kennedy, MD, Sushma Bharadwaj, MD, David J Iberri, MD, Michaela Liedtke, MD, Yasodha Natkunam, MD, PhD, Dita Gratzinger, MD, PhD, Parveen Shiraz, MD, Wen-Kai Weng, MD, PhD, Melody Smith, MD, Matthew Frank, MD, PhD, Crystal L. Mackall, M.D., Saurabh Dahiya, MD, David B. Miklos, MD, PhD, Hitomi Hosoya, MD PhD, and Surbhi Sidana, MD  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665894

581 The Impact of Extramedullary Multiple Myeloma on Treatment Outcomes with Teclistamab: U.S. Myeloma Immunotherapy Consortium Real World Experience

Aimaz Afrough, MD, Danai Dima, MD, Beatrice Razzo, MD, Aishwarya Sannareddy, MBBS, Oren Pasvolsky, MD, Mariola A Vasquez-Martinez, MD, Christopher James Ferreri, MD, Rahul Banerjee, MD, Jack Khouri, MD, James A. Davis, PharmD, BCOP, Mahmoud Gaballa, MD, Alex Lieberman-Cribbin, MPH, Masooma Shifa Rana, Utkarsh Goel, MBBS, Kelley L Julian, PharmD, BCOP, Faiz Anwer, MD, Leyla Shune, MD, Mr. Shaun DeJarnette, BS, MT(ASCP), Ariel Grajales-Cruz, MD, Evguenia Ouchveridze, MD, Gabriel De Avila, BS, Sandra Susanibar-Adaniya, MD, Andrew J. Portuguese, MD, Daniel Schrum, PharmD, Erin Eberwein, PharmD, Hitomi Hosoya, MD PhD, Lekha Mikkilineni, MD, Gurbakhash Kaur, MD, Joseph P McGuirk, DO, Adriana Rossi, MD, Megan M. Herr, PhD, Omar Castaneda, MD, Frederick L Locke, MD, Shahzad Raza, MD, Yi Lin, MD, PhD, Shebli Atrash, MD, Douglas W. Sborov, MD, Peter M. Voorhees, Shambavi Richard, MD, Alfred L. Garfall, MD, Surbhi Sidana, MD, Krina K. Patel, MD, MS, Doris K Hansen, MD, Andrew J. Cowan, MD, Larry D. Anderson Jr., MD, PhD, and Hans C. Lee, MD 

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665900

588 The Impact of Anti-CD38-Monoclonal Antibody Therapy on Stem-Cell Mobilization Yields in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Real-World Data 2021-2023

Dilek Uzun, MD, Inna Kaplan, DNP, RN, OCN, CNL, Sally Arai, MD, Sushma Bharadwaj, MD, Laura Johnston, MD, Robert Lowsky, MD, Lori S. Muffly, MD, Robert S. Negrin, MD, Andrew R. Rezvani, MD, Parveen Shiraz, MD, Judith A. Shizuru, MD, PhD, Wen-Kai Weng, MD, PhD, Hitomi Hosoya, MD PhD, Surbhi Sidana, MD, and Lekha Mikkilineni, MD  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665907

611 Recommendations for Defining Chimeric Antigen Receptor T-Cell (CAR T) Dose-Limiting Toxicities (DLTs) for Future Early-Stage CAR T Therapy Studies

Frederick L Locke, MD, Sarah Nikiforow, MD, PhD, Matthew Frigault, MD, David G. Maloney, MD, PhD, Dr. Marco L. Davila, MD, PhD, David B. Miklos, MD, PhD, Yi Lin, MD, PhD, Judy Vong, MS, Kirstin Liechty, BS, Nirav N. Shah, MD, William Y. Go, MD, PhD, Wendy J. Langeberg, PhD, Sattva S. Neelapu, MD, John Welch, MD, PhD, Eric Ng, MD, Caron A. Jacobson, MD, MMSc, and Marcela V. Maus, MD, PhD  

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/666838

617 Outcomes of Adults with Acute Myeloid Leukemia Who Received Venetoclax Therapy before Allogeneic Hematopoietic Cell Transplantation

Andrew Artz, MD, Kwang Woo Ahn, Wentong Liu, Courtney D. DiNardo, Lori S. Muffly, MD, Uday R. Popat, MD, Vinod Pullarkat, MD, Catherine Miller, Dr. Jean Ridgeway, and Linda J. Burns

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665470

632 BMT Post Fall with Head Injury Algorithm:  A Standardized Approach 

Mazur, Diana, Ranieri, Emily, Wu, Beth

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/666101

693 Making the Shift:  Streamlining the Transition from Oncology to the Blood and Marrow Transplant and Cellular Therapy Specialty

Kalaw, Karen, Latchford, Theresa, Mazur, Diana, Ranieri, Emily, Wang, Yanli

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/665936

730 Beyond Treatment: Empowering Recovery and Promoting Long-Term Health with Personalized Survivorship Care Plans (SCP) in Hematopoietic Stem Cell Transplant (HCT) Recipients
Inna Kaplan, DNP, RN, OCN, CNL, Cherri Parulan, FNP-C, Theresa Brondstetter, RN, FNP-C, CNS, Maricris Dacumos, MSN, NP, FNP-BC, AOCNP-BC, Mr. Lenito Navarro, PA-C, Jennifer Kim, MD, and Laura Johnston, MD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/666848

Phase II Multicenter Trial of Idecabtagene Vicleucel (Ide-cel) Followed By Lenalidomide Maintenance for Multiple Myeloma Patients with Sub-Optimal Response after an Upfront Autologous Hematopoietic Cell Transplantation: Top Line Results from the BMT CTN 1902 Clinical Trial

Saturday, February 15, 2025 

03:15 PM - 03:33 PM HST

Ballroom B (HCC)

Alfred L. Garfall, MD, Marcelo C. Pasquini, MD, Ling Bai, PhD, Erica Anderson, MA, David Avigan, MD, Natalie S. Callander, MD, Taewoong Choi, MD, Adam D. Cohen, Binod Dhakal, MD, Nancy Geller, PhD, Patrick A. Hagen, MD, Myo Htut, MD, Brent R. Logan, PhD, Premal D. Lulla, MD, Thomas Martin, Philip L. McCarthy, MD, Laura Morrison, MSc, Taiga Nishihori, MD, Shambavi Richard, MD, Jennifer Romeril, BSN, RN, Surbhi Sidana, MD, Alec Rose, Ashley Spahn, Edward A. Stadtmauer, MD, Joseph D Tario, PhD, Saad Z. Usmani, MD, Indumathy Varadarajan, MD, and Sergio A. Giralt, MD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/666867

A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Alpha-1-Antitrypsin for Treatment of High Risk Acute Gvhd (BMT CTN 1705)

Saturday, February 15, 2025 

03:33 PM - 03:51 PM HST

Ballroom B (HCC)

John Magenau, MD, Mehdi Hamadani, MD, Ling Bai, PhD, Michael J. Martens, PhD, Sameem Abedin, MD, Sally Arai, MD, Doris M. Ponce, MD, Najla El Jurdi, MD, Hannah K. Choe, MD, Masumi Ueda Oshima, MD, MA, Joseph Pidala, MD, PhD, Scott R. Solomon, MD, Aleksander L. Chojecki, MD, Nancy Geller, PhD, Nancy DiFronzo, PhD, Lori Henderson, PhD, Elizabeth J. Shpall, MD, Pavan Reddy, MD, Terry Pritchard, MS, Jenna McGuirk, MS, CCRA, Jennifer Romeril, BSN, RN, Adam Mendizabal, PhD, Betty K. Hamilton, MD, LaQuisa C. Hill, MD, John Koreth, MBBS, DPhil, Muna Qayed, MD, MSc, Mark A Schroeder, MD, MSCI, Yuanyuan Wang, PhD, Ralph Preiss, MD, Laurie A Lee, MD, Laura Morrison, MSc, H. Joachim Deeg, MD, Gregory A Yanik, MD, and Amin M. Alousi, MD

https://vmx.m-anage.com/us/tandem2025/en-US/presentation/666868